The Healthy Gente program aims to develop preventive goals, objectives and strategies, resulting in a strategic management tool that will be used by the U.S. border states, communities and many other public- and private-sector partners.
Within each border state, the Healthy Gente program will be implemented in border communities by a consortium of state and local organizations, including the state health office, border health office, local health departments, private health programs, and private businesses, with the border health office taking the lead. The border health office will assist communities in assembling data on the 25 objectives, selecting the focus objectives for the project, and working to allocate health resources to address the focus objectives. This presentation will review progress to date in establishing community projects in each of the U.S. border states.
Mexico has a national health indicators program that tracks trends in 42 key health measures at the national, state and local levels. Matching Mexico's 42 health indicators with the 25 objectives of the Healthy Gente program yields 19 common measures. These 19 measures have been selected as the basis of a binational Healthy Border program. Mexico has set targets for each of these indicators, and will design activities in the border communities of Mexico to accomplish these targets within the decade. In many cases, communities on both sides of the border, facing similar health issues, will develop binational projects to address common problems.
Learning Objectives: 1)Describe the major health and socioeconomic disparities between those living along the southern U.S. border with Mexico 2)Identify the key provisions of PL 103-400: The U.S.-Mexico Border Health Commission Act 3)Describe the USMBHC's two primary goals and what the Commission is authorized to do. 4)Identify the Commission's implementation actions from 1994 through mid-2001. 5)Identify the 14 areas addressed by the 25 Healthy Gente 2010 objectives
Keywords: International Health,
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.